Cargando…
Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior
Cyclin-dependent kinase 5 (Cdk5) is a crucial regulator of neuronal signal transduction. Cdk5 activity is implicated in various neuropsychiatric and neurodegenerative conditions such as stress, anxiety, depression, addiction, Alzheimer’s disease, and Parkinson’s disease. While constitutive Cdk5 knoc...
Autores principales: | Umfress, Alan, Singh, Sarbjit, Ryan, Kevin J., Chakraborti, Ayanabha, Plattner, Florian, Sonawane, Yogesh, Mallareddy, Jayapal Reddy, Acosta, Edward P., Natarajan, Amarnath, Bibb, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134315/ https://www.ncbi.nlm.nih.gov/pubmed/35645825 http://dx.doi.org/10.3389/fphar.2022.863762 |
Ejemplares similares
-
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase
por: Rana, Sandeep, et al.
Publicado: (2021) -
Cdk5 mediates rotational force-induced brain injury
por: Umfress, Alan, et al.
Publicado: (2023) -
Integrated regulation of PKA by fast and slow neurotransmission in the nucleus accumbens controls plasticity and stress responses
por: Thomas, Rachel, et al.
Publicado: (2022) -
Editorial: Experimental Models of Epilepsy and Related Comorbidities
por: Chakraborti, Ayanabha, et al.
Publicado: (2019) -
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
por: Kour, Smit, et al.
Publicado: (2022)